Company Valuation: BioNTech SE

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 54,749 34,159 22,698 26,387 19,497 20,202 - -
Change - -37.61% -33.55% 16.25% -26.11% 3.62% - -
Enterprise Value (EV) 1 53,358 20,496 11,253 16,879 12,356 9,423 10,760 11,246
Change - -61.59% -45.1% 50% -26.8% -23.74% 14.19% 4.52%
P/E 5.72x 3.72x 24.9x -39.7x -17.3x -14.6x -15.2x -19.7x
PBR 4.62x 1.7x 1.12x - 1.06x 1.15x 1.24x 1.34x
PEG - -0.79x -0.3x 0x -0.2x -0.9x 3.92x 0.9x
Capitalization / Revenue 2.89x 1.97x 5.94x 9.59x 6.79x 11x 10.8x 8.71x
EV / Revenue 2.81x 1.18x 2.95x 6.14x 4.31x 5.15x 5.77x 4.85x
EV / EBITDA 3.47x 1.61x 12.9x -16.6x -12.1x -6.72x -7.31x -10.4x
EV / EBIT 3.49x 1.62x 16.3x -12.8x -8.79x -5.3x -6.34x -8.9x
EV / FCF 72.5x 1.55x 2.41x -69x 44x -5.4x -6.51x -7.9x
FCF Yield 1.38% 64.5% 41.5% -1.45% 2.27% -18.5% -15.4% -12.7%
Dividend per Share 2 - - - - - - - -
Rate of return - - - - - - - -
EPS 2 39.63 37.77 3.83 -2.77 -4.7 -5.507 -5.294 -4.073
Distribution rate - - - - - - - -
Net sales 1 18,977 17,311 3,819 2,751 2,870 1,830 1,864 2,318
EBITDA 1 15,359 12,766 873.8 -1,016 -1,022 -1,403 -1,472 -1,080
EBIT 1 15,284 12,643 690.4 -1,314 -1,405 -1,779 -1,697 -1,263
Net income 1 10,292 9,434 930.3 -665.3 -1,136 -1,341 -1,339 -1,002
Net Debt 1 -1,391 -13,663 -11,445 -9,508 -7,141 -10,779 -9,442 -8,956
Reference price 2 226.68 140.56 95.48 110.06 81.08 80.42 80.42 80.42
Nbr of stocks (in thousands) 241,521 243,019 237,716 239,740 240,455 251,204 - -
Announcement Date 3/30/22 3/27/23 3/20/24 3/10/25 3/10/26 - - -
1EUR in Million2EUR
Estimates

P/E, Detailed evolution

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
-14.6x5.15x-6.72x-.--% 23.31B
21.1x7.39x15.06x1.37% 70.51B
30.8x7.85x23.9x0.05% 54.05B
-86.72x15.69x-80x-.--% 28.95B
30.53x5.98x15.83x-.--% 24.05B
25.16x4.78x16.02x-.--% 18.37B
56.06x22.95x59.1x0.07% 18.67B
-1224.8x38.15x-15183.55x-.--% 16.1B
15.92x4.69x10.95x-.--% 12.72B
-25.16x25.45x-28.34x-.--% 12.61B
Average -117.17x 13.81x -1,515.78x 0.15% 27.93B
Weighted average by Cap. -61.90x 11.36x -869.96x 0.36%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

Year-on-year evolution of the Yield

  1. Stock Market
  2. Stocks
  3. BNTX Stock
  4. Valuation BioNTech SE